Türkiye's SGK funds 7.4 billion lira in child leukemia care

Türkiye's Social Security Institution (SGK) said it is supporting the testing, analysis and treatment of children with leukemia. According to the statement, in the first seven months of the year, 4.209 billion lira was provided for testing and treatment expenses, 3.204 billion lira for drugs and 18 million lira for medical devices, bringing total health spending financed to 7.431 billion lira.

The statement also noted that 112 drugs used in the treatment phase are covered under reimbursement. The institution's announcement put the figures for leukemia care on public record. The report was published by Anadolu Agency on 7 November 2026.